Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa Nebie

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
International Journal for Parasitology|May 9, 2018
Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feedingLynn Grignard, Bronner P Gonçalves, Angela M Early, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trialAndré Lin Ouédraogo, Guido J H Bastiaens, Alfred B Tiono, et al.
Plos One|November 19, 2013
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of ageAlphonse Ouédraogo, Alfred B Tiono, Désiré Kargougou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2008
Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malariaMaria G Torcia, Veronica Santarlasci, Lorenzo Cosmi, et al.
Frontiers in Immunology|November 1, 2023
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trialAlphonse Ouédraogo, Edith Christiane Bougouma, Nirianne Marie Q Palacpac, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
International Journal for Parasitology|May 9, 2018
Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feedingLynn Grignard, Bronner P Gonçalves, Angela M Early, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trialAndré Lin Ouédraogo, Guido J H Bastiaens, Alfred B Tiono, et al.
Plos One|November 19, 2013
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of ageAlphonse Ouédraogo, Alfred B Tiono, Désiré Kargougou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2008
Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malariaMaria G Torcia, Veronica Santarlasci, Lorenzo Cosmi, et al.
Frontiers in Immunology|November 1, 2023
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trialAlphonse Ouédraogo, Edith Christiane Bougouma, Nirianne Marie Q Palacpac, et al.
Pageof 5